| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 30-Sep-08 | | Total Revenue | 42,782 | 37,416 | 41,251 | 87,811 | | Cost of Revenue | 35,807 | 31,675 | 35,681 | 74,398 | | | Gross Profit | 6,975 | 5,741 | 5,570 | 13,413 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,526 | 6,568 | 7,123 | 11,389 | | Non Recurring |
-
| 7,152 |
-
|
-
| | Others |
-
|
-
|
-
| 2,393 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (551) | (7,979) | (1,553) | (369) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 65 | 567 | 2,308 | 2,597 | | Earnings Before Interest And Taxes | (486) | (7,412) | 755 | 2,228 | | Interest Expense | 161 | 177 | 231 | 840 | | Income Before Tax | (647) | (7,589) | 524 | 1,388 | | Income Tax Expense | 722 | (154) | (154) | 484 | | Minority Interest | 94 | (1) | 1 | (39) | | | | Net Income From Continuing Ops | (1,275) | (7,436) | 679 | 865 | | | Non-recurring Events | | Discontinued Operations | 465 | (1,238) | (1,234) | 147 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (810) | (8,674) | (555) | 1,012 | | Preferred Stock And Other Adjustments | (90) | 90 |
-
|
-
| | | Net Income Applicable To Common Shares | ($900) | ($8,584) | ($555) | $1,012 |
|
0.02% Nasdaq 
0.03 (0.51%) 
Income Statement
